Fidelity New Millennium Fund earns an Above Average Process Pillar rating. The most important driver of the rating is its parent firm's superior long-term risk-adjusted performance, as shown by ...

Milestone announced further details on its in-person and virtual Commercial Launch Plan investor event to take place in New York on Tuesday, ...

Oppenheimer initiated coverage of ARS Pharmaceuticals (SPRY) with an Outperform rating and $40 price target As the first and only approved needle-free epinephrine product, neffy has the potential ...

Kerr-McGee and the Town of Firestone have come to the end of an agreement that called for a $4 million cash payment to the ...

FORT COLLINS — Mark Weiss has joined Platte River Power Authority as chief technology officer, a new position with the ...

Rocket Pharmaceuticals (RCKT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

In today’s fast-paced world, threats can evolve quickly and without warning. As the pharmaceutical industry has operations and supply chains spanning the globe, companies are vulnerable to ...

2025 The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.

Infinity Pharmaceuticals Inc. 0.00% $90.76 ...

IPC Indice de Precios Y Cotizaciones 52,817.75 142.96 0.27% ...